CFGS
XBI icon

Concourse Financial Group Securities’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Concourse Financial Group Securities’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-515
Closed -$47K – 2118
2024
Q4 		$47K Hold
515
– – ﹤0.01% 1242
2024
Q3 		$50.9K Hold
515
– – ﹤0.01% 1180
2024
Q2 		$47.7K Buy
515
+22
+4% +$1.97K ﹤0.01% 1191
2024
Q1 		$46.8K Sell
493
-165
-25% -$15.3K ﹤0.01% 1209
2023
Q4 		$58.8K Buy
658
+115
+21% +$8.54K ﹤0.01% 1083
2023
Q3 		$39.6K Hold
543
– – ﹤0.01% 1167
2023
Q2 		$45.2K Sell
543
-90
-14% -$7.53K ﹤0.01% 1133
2023
Q1 		$48.2K Hold
633
– – ﹤0.01% 1109
2022
Q4 		$52.5K Hold
633
– – ﹤0.01% 1050
2022
Q3 		$50K Hold
633
– – ﹤0.01% 947
2022
Q2 		$47K Sell
633
-275
-30% -$20.6K ﹤0.01% 1122
2022
Q1 		$82K Buy
908
+67
+8% +$6.19K 0.01% 946
2021
Q4 		$94K Sell
841
-18
-2% -$2.17K 0.01% 1032
2021
Q3 		$108K Sell
859
-213
-20% -$27.4K 0.01% 954
2021
Q2 		$145K Sell
1,072
-34,325
-97% -$4.51M 0.01% 830
2021
Q1 		$4.8M Sell
35,397
-2,706
-7% -$405K 0.34% 64
2020
Q4 		$5.36M Buy
38,103
+917
+2% +$117K 0.4% 53
2020
Q3 		$4.14M Buy
37,186
+36,160
+3,524% +$4.05M 0.36% 59
2020
Q2 		$115K Buy
1,026
+15
+1% +$1.48K 0.01% 687
2020
Q1 		$78K Buy
1,011
+30
+3% +$2.66K 0.01% 746
2019
Q4 		$93K Buy
981
+202
+26% +$17.5K 0.01% 736
2019
Q3 		$59K Sell
779
-956
-55% -$79.5K 0.01% 572
2019
Q2 		$152K Buy
1,735
+531
+44% +$45.3K 0.02% 549
2019
Q1 		$108K Buy
1,204
+523
+77% +$44.5K 0.01% 663
2018
Q4 		$48K Sell
681
-1,473
-68% -$119K 0.01% 832
2018
Q3 		$207K Buy
+2,154
New +$209K 0.06% 279

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Concourse Financial Group Securities's XBI Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 515 shares — an estimated $47K sold.

Concourse Financial Group Securities first reported a position in XBI in Q3 2018 and held it in 26 quarters. The position peaked at $5.36M in Q4 2020. 683 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 515 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $47K.
  • Concourse Financial Group Securities first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and held it in 26 quarters.
  • Concourse Financial Group Securities's State Street SPDR S&P Biotech ETF position peaked at $5.36M in Q4 2020.
  • 683 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.